Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]

MDMA

Brief Summary

The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.

Intervention / Treatment

  • Drug: MDA
  • Drug: Placebo

Condition or Disease

  • Healthy

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 18 Years to 50 Years   (Adult)
Enrollment: 12 ()
Funded by: Other|NIH

Masking

Clinical Trial Dates

Start date: Jan 01, 2009
Primary Completion: Jul 01, 2009
Completion Date: Jul 01, 2009
Study First Posted: Jan 15, 2009
Last Updated: May 31, 2013

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Location

San Francisco, California, USA

Eligibility Criteria

Sex: All

More Details

NCT Number: NCT00823407
Acronym: MDA
Other IDs: 27.112|IND# 79,632|5R01DA016776|CHR# H6637-31759-01|IRB# 27.112|RAP-C# 0740
Study URL: https://ClinicalTrials.gov/show/NCT00823407
Last updated: Jun 17, 2022